Nomura Holdings’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-381,770
| Closed | -$3.85M | – | 1000 |
|
|
2022
Q4 | $3.85M | Buy |
381,770
+230,554
| +152% | +$2.32M | 0.02% | 307 |
|
|
2022
Q3 | $3.41M | Buy |
151,216
+114,967
| +317% | +$2.59M | 0.01% | 373 |
|
|
2022
Q2 | $909K | Buy |
+36,249
| New | +$909K | ﹤0.01% | 647 |
|
|
2021
Q3 | – | Sell |
-2,570
| Closed | -$224K | – | 1603 |
|
|
2021
Q2 | $224K | Sell |
2,570
-6,430
| -71% | -$560K | ﹤0.01% | 1327 |
|
|
2021
Q1 | $741K | Buy |
+9,000
| New | +$741K | ﹤0.01% | 860 |
|
|
2016
Q1 | – | Sell |
-13,000
| Closed | -$44K | – | 1242 |
|
|
2015
Q4 | $44K | Buy |
+13,000
| New | +$44K | ﹤0.01% | 1297 |
|